Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter

Your Location：

Home >

Browse articles >

Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter

Updated：2026-03-12

- Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter
- Military Medical Research Vol. 0, Issue 3, Pages: 178-182(1998)
- Affiliations：
- Author bio：
- Funds：
- DOI：
  CLC： R456
- Published：1998
- Accepted：
Scan QR Code
Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. Military Medical Research1998, 0(3): 178-182.
DOI：

Gene therapy for malignant melanoma using bacterial cytosine deaminase gene under the control of tyrosinase promoter[J]. Military Medical Research1998, 0(3): 178-182. DOI：

摘要

Abstract

关键词

Keywords

references

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

Ionizable drug delivery systems for efficient and selective gene therapy

Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3

Related Author

Guang-Tong Deng

Xiang Chen

Fu-Rong Zeng

Ming-Zhu Yin

Hui Su

Yi-Huang Liu

Qian Zhou

Yi He

Related Institution

Department of Oncology, Xiangya Hospital, Central South University

Department of Breast Reconstruction, Tianjin Medical University Cancer Institute and Hospital

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital

Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University

Furong Laboratory

⁰